Advertisement
Advertisement
LAB
Standard BioTools Inc. Common Stock
0.66
USDSponsored
-0.02
-3.29%
Aug 18, 15:59 UTC -4
Closed
After-Market
0.70
+0.04
+5.74%
LAB Earnings Reports
Positive Surprise Ratio
LAB beat 17 of 37 last estimates.
46%
Next Report
Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$18.60M
/-$0.02
Implied change from Q2 26 (Revenue/ EPS)
-7.48%
/-33.33%
Implied change from Q3 25 (Revenue/ EPS)
-4.87%
/-77.78%
Standard BioTools Inc. Common Stock earnings per share and revenue
On Aug 05, 2026, LAB reported earnings of -0.03 USD per share (EPS) for Q2 26, missing the estimate of -0.01 USD, resulting in a -129.01% surprise. Revenue reached 20.10 million, compared to an expected 21.01 million, with a -4.32% difference. The market reacted with a +2.04% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -0.02 USD, with revenue projected to reach 18.60 million USD, implying an decrease of -33.33% EPS, and decrease of -7.48% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Claritev Corporation
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$4.21
Actual
-$3.49
Surprise
+17.12%
Senseonics Holdings, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.63
Actual
-$0.63
Surprise
+1.13%
CapsoVision, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.15
Surprise
-12.02%
Insight Molecular Diagnostics Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.24
Actual
-$0.23
Surprise
+7.67%
CareCloud, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.06
Actual
$0.06
Surprise
-7.12%
Neuraxis, Inc.
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.32
Actual
-$0.19
Surprise
+41.79%
P3 Health Partners Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$1.93
Actual
-$0.63
Surprise
+67.41%
Hims & Hers Health, Inc.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.01
Actual
-$0.10
Surprise
-599.30%
Heartflow, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.07
Surprise
+48.68%
MDxHealth SA Ordinary Shares
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.19
Actual
-$0.18
Surprise
+9.04%
FAQ
What were Standard BioTools Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Standard BioTools Inc. Common Stock reported EPS of -$0.03, missing estimates by -129.01%, and revenue of $20.10M, -4.32% below expectations.
How did the market react to Standard BioTools Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 2.04%, changed from $0.78 before the earnings release to $0.80 the day after.
When is Standard BioTools Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 02, 2026.
What are the forecasts for Standard BioTools Inc. Common Stock's next earnings report?
Based on 4
analysts, Standard BioTools Inc. Common Stock is expected to report EPS of -$0.02 and revenue of $18.60M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement